THE AGE AT WHICH TESTOSTERONE STARTS DECREASING IN MEN NOW-A-DAYS
KHYBER MEDICAL UNIVERSITY JOURNAL 2012;4(4)
PDF

How to Cite

Rahman, U., Hamid, N., , U., Ahmad, N., Safeer, M., Tariq, M., & Rehman, J. (2012). THE AGE AT WHICH TESTOSTERONE STARTS DECREASING IN MEN NOW-A-DAYS. KHYBER MEDICAL UNIVERSITY JOURNAL, 4(4), 174-178. Retrieved from https://www.kmuj.kmu.edu.pk/article/view/9720

Abstract

Objective: The aim of this study was to determine the age at which testosterone starts decreasing in male subjects. Methodology: This comparative study was conducted on two groups; group 1 included male subjects with 18–21 years of age and group 2 included male subjects with 22–25 years of age. Subjects having history of hypogonadism,hyperthyroidism, hypothyroidism, mental illness like depression were all excluded. Serum testosterone was analyzed by Radio-Immuno Assay method on gamma counter in Institute of Radiotherapy and Nuclear Medicine (IRNUM), Peshawar.The serum testosterone levels of the two groups were compared for a significant difference by using student-t test. Results: Group 1 included 80 subjects and group 2 had 75 patients. In group 1, testosterone level was >12 ng/ml in 22.5% (n=18/80), 7-12ng/ml in 58.75% (47/80) and <7 ng/ml in 18.75% (n=15/80) cases. In group 2, testosterone level was >12 ng/ml in 8% (n=6/75), 7-12ng/ml in 54.6% (n=41/75) and <7 ng/ml in 37.3% (n=28/75) cases. Mean testosterone level was 9.40±2.986 ng/ml in group 1 and 7.89±2.891 ng/ml in group 2 (p<0.05). Conclusion: The testosterone level in male subject is significantly lowered at 22–25 years of age as compared to 18–21 years of age. Well planned and large scale studies are required to address the issue in detail and to find out the causes of early decline of the testosterone level in young male subjects. Keywords: Testosterone, Aging, Hypogonadism, Optimal Health This article may be cited as: Rahman UU, Hamid N, Ubaidullah , Ahmad N, Safeer M, Tariq M, et al. The age at which testosterone starts decreasing in men now-a-days. Khyber Med Univ J 2012; 4(4): 174-178.
PDF

References

Life JS, Mintz AP. “A Second Confirmation for the Benefits

of HRT for Men.” Retrieved October 2012 from http://

healthfully.org/malehormones/id11.html

Lo Y. Estimating Age-specific Prevalence of Testosterone

Deficiency in Men Using Normal Mixture Models. J Data

Science 2009; 7: 203-217.

Swerdloff RS, Wang C. The testis and male sexual function.

In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th

ed. Philadelphia, Pa: Saunders Elsevier; 2011: pp. 242.

Topiwala S. “Testosterone” Retrieved 22nd March, 2012

from www.nlm.nih.gov/medlineplus/ency/article/003707.

htm

Nahoul K, Roger M. Age-related decline of plasma bioavailable testosterone in adult men. J Steroid Biochem

; 35(2): 293-9.

Okamura K, Ando F, Shimokata H. Serum total and free

testosterone level of Japanese men: A population-based

study. Int J Urol 2005; 12: 810-4.

Sternbach, H. Age-associated testosterone decline in

men: clinical issues for psychiatry. Am J Psychiatry

;155(10): 1310-8.

Wang X, Shen CL, Dyson MT, Eimerl S, Orly J, Hutson

JC, et al. Cyclooxygenase-2 regulation of the age-related

decline in testosterone biosynthesis. Endocrinology

; 146(10): 4202- 8.

Purifoy FE, Koopmans LH, Mayes DM. Age differences

in serum androgen levels in normal adult males. Hum

Biol 1981;53: 499–511.

Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman

MR. Baltimore Longitudinal Study of Aging. Longitudinal

effects of aging on serum total and free testosterone

levels in healthy men. J Clin Endocrinol Metab 2001;

: 724–31.

Travison TG, Araujo AB, Kupelian V, O’Donnell AB,

McKinlay JB. The relative contributions of aging, health,

and lifestyle factors to serum testosterone decline in

men. J Clin Endocrinol Metab 2007; 92: 549-55.

Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW,

et al. European Male Aging Study Group. Hypothalamic-

pituitary-testicular axis disruptions in older men are

differentially linked to age and modifiable risk factors. J

Clin Endocrinol Metab 2008; 93: 2737-45.

Shanti Med spa, Testosterone for Men: Optimal Health

Today. Retrieved November 2012 from http://optimalhealthtoday.

com/optimal-health/bio-identical-hormones/

mens-health/

Jones GE, Baker K, Fahmy DR, Boyns AR, Leifke E. Effect

of luteinizing hormone releasing hormone on plasma

levels of luteinizing hormone, oestradiol and testosterone

in the male dog. J Endocrinol 1976; 68: 469-474.

Leifke E, Gorenoi V, Wichers C, Von Zur Mühlen A, Von

Büren E, Brabant G, et al. Age-related changes of serum

sex hormones, insulin-like growth factor-1 and sex-hormone

binding globulin levels in men: cross-sectional

data from a healthy male cohort. Clin Endocrinol (Oxf).

; 53: 689-9.

Marcell TJ, Harman SM, Urban RJ, Metz DD, Rodgers

BD, Blackman MR. Comparison of GH, IGF-I, and testosterone

with mRNA of receptors and myostatin in skeletal

muscle in older men. Am J Physiol Endocrinol Metab

; 281: 1159-64.

St. Louis, Is there a Male ‘Menopause? Retrieved from

December 7, 2012 http://www.usdoctor.com/testone.htm

Mazur A, Booth A. “Testosterone and dominance in

men.” Behavioral Brain Sci 1998; 21(3): 353-97.

Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope

C, Liu K. Serum androgen concentrations in young men:

a longitudinal analysis of association with age, obesity

and race. The Cardia Male Hormone Study. Cancer

Epidemiol Biomarkers Preven 2002; 11: 1041-7.

Field AE, Colditz GA, Willett WC, Longcope C, Mc-Kinlay

JB. The relation of smoking, age, relative weight and

dietary intake to serum adrenal steroids, sex hormones

and sex hormone-binding globulin in middle-aged men.

J Clin Endocrinol Metab 1994; 79:1310-16.

Wang XJ, Dyson MT, Mondillo C, Patrignani Z, Pignataro

O, Stocco DM. Interaction between arachidonic acid and

cAMP signaling pathways enhances steroidogenesis

and StAR gene expression in MA-10 Leydig tumor cells.

Mol Cell Endocrinol 2002; 188: 55–63.

Ronco AM, Moraga PF, Llanos MN. Arachidonic acid release

from rat Leydig cells: the involvement of G protein,

phospholipase A2 and regulation of cAMP production.

J Endocrinol 2002; 172: 95–104.

Wang X, Walsh LP, Reinhart AJ, Stocco DM. The role of

arachidonic acid in steroidogenesis and steroidogenic

acute regulatory (StAR) gene and protein expression. J

Biol Chem 2000; 275: 20204–9.

Wang XJ, Dyson MT, Jo Y, Eubank DW, Stocco DM. Involvement

of 5-lipoxygenase metabolites of arachidonic

acid in cyclic AMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. J

Steroid Biochem Mol Biol 2003b; 85: 159–66.

Shea-Eaton W, Sandhoff TW, Lopez D, Hales DB, McLean

MP. Transcriptional repression of the rat steroidogenic

acute regulatory (StAR) protein gene by the AP-1 family

member c-Fos. Mol Cell Endocrinol 2002; 188: 161–70.

Stewart KG, Zhang Y, Davidge ST. Aging increases

PGHS- 2-dependent vasoconstriction in rat mesenteric

arteries. Hypertension 2000; 35: 1242–7.

Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation

hypothesis of aging: molecular modulation by calorie

restriction. Ann NY Acad Sci 2001; 928: 327–35.

Syntin P, Chen H, Zirkin BR, Robaire B. Gene expression

in Brown Norway rat Leydig cells: effects of age and

of age-related germ cell loss. Endocrinol 2001; 142:

–85.

Wang XJ, Shen CL, Dyson MT, Hutson JC, Stocco DM.

c. Cyclooxygenase-2 and its inhibitors in StAR gene

expression and testosterone biosynthesis in aged male

rats. In: Proceedings of the Annual Healthy Aging Symposium:

Ages and Stages, Lubbock, Texas.

Wang XJ, Dyson MT, Jo Y, Stocco DM. Inhibition of cyclooxygenase 2 activity enhances steroidogenesis and

steroidogenic acute regulatory gene expression in MA-10

mouse Leydig cells. Endocrinol 2003a; 144: 3368–75.

Gao HB, Shan LX, Monder C, Handy MP. Supression

of endogenous corticosterone levels in vivo increases

the steroidogeneic capacity of purified rat Leidig cells

in vitro. Endocrinol 1996; 137: 1714–8.

Roy M, Kirschbaum C, Steptoe A. Intraindividual variation

in recent stress exposure as a moderator of cortisol and

testosterone levels. Ann Behav Med 2003; 26: 194–200.

Gao HB, Tong MH, Hu YQ, Guo QS, Ge R, Hardy MP.

Glucocolticoid induces apoptosis in rat Leidig cells.

Endocrinol 2002; 143: 130–8.

Midzaka AS, Chen H, Papadopoulos V, Zirkin BR. Leydig cell aging and the mechanisms of reduced testosterone

synthesis. Molecular and Cellular Endocrinology 2009;

: 23–31.

Work published in KMUJ is licensed under a

 Creative Commons Attribution-NonCommercial 2.0 Generic License.

Creative Commons License

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.